Legend Biotech Corporation header image

Legend Biotech Corporation

LEGN

Equity

ISIN null / Valor 54834759

NASDAQ (2026-02-26)

USD 19.28-2.23%

Legend Biotech Corporation
UMushroom community rating:

4.00 10 votes No rating yet

NegativeNeutralPositive

About company

Legend Biotech Corporation is a biotechnology company focused on developing investigational agents and innovative technologies in personalized medicine, with a particular emphasis on cell therapies for treating hematological malignancies and solid tumors. The company is dedicated to exploring the potential of cell therapies to address diseases that are considered intractable and incurable. Through its pipeline of cutting-edge therapies, Legend Biotech aims to provide new treatment options for patients with challenging medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-47.2%1Y

-57.4%3Y

-29.1%5Y

Performance

48.3%1Y

46.6%3Y

51.7%5Y

Volatility

3561 M

Market cap (USD)

1,727,145

Daily traded volume (Shares)

32.9 / 32.18

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

10 votes

Performance:

4.03

Innovation:

4.41

Society:

4.03

Nature:

4.00

Thomas Yarwood

United Kingdom, 25 Feb 2026

Growth potential

ola ho

United Kingdom, 22 Feb 2026

n/a

Robert Higley

United Kingdom, 17 Feb 2026

Great potential

EQUITIES OF THE SAME SECTOR

QuidelOrtho Corporation

QuidelOrtho Corporation Valor: 119356965

Annual Return

-50%0%+50%

Risk level

110

-2.70%USD 22.70

iRhythm Technologies Inc

iRhythm Technologies Inc Valor: 34117792

Annual Return

-50%0%+50%

Risk level

110

3.15%USD 140.18

Novartis Inc

Novartis Inc Valor: 1200526

Annual Return

-50%0%+50%

Risk level

110

-1.31%CHF 128.10

Savaria Corp

Savaria Corp Valor: 1385257

Annual Return

-50%0%+50%

Risk level

110

0.47%CAD 25.72

Johnson & Johnson

Johnson & Johnson Valor: 943981

Annual Return

-50%0%+50%

Risk level

110

-0.69%USD 243.47

Novo Nordisk A/S

Novo Nordisk A/S Valor: 461641

Annual Return

-50%0%+50%

Risk level

110

-1.42%USD 37.62

Merck & Co Inc

Merck & Co Inc Valor: 10683053

Annual Return

-50%0%+50%

Risk level

110

-2.58%USD 119.30

Pfizer Inc

Pfizer Inc Valor: 962004

Annual Return

-50%0%+50%

Risk level

110

0.04%USD 27.10

Abbott Laboratories

Abbott Laboratories Valor: 903037

Annual Return

-50%0%+50%

Risk level

110

1.31%USD 116.26

Essity AB

Essity AB Valor: 36846754

Annual Return

-50%0%+50%

Risk level

110

0.52%SEK 288.50

SIX

FactSet

Clearbit

Logos provided by Clearbit